Diligence memo · auto-generated · as of July 2, 2026

Kenota (formerly ExVivo Labs)

Kenota (formerly ExVivo Labs): limited disclosed financing to assess.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Kenota (formerly ExVivo Labs) operates in Software / Tech, based in Kitchener, ON, Canada. Kenota is revolutionizing the way we test for disease

Sub-sector tags: Healthcare, Diagnostics.

Capital & rounds (filed)filed

Kenota (formerly ExVivo Labs) has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.

Valuation (modeled)modeled

No modeled valuation — too little disclosed financing to estimate one.

Financing rhythm & timingmixed

Not enough dated financing history to read a financing rhythm.

Comparablesmixed

Capital scale ranks ahead of 2% of Software / Tech peers (3920 compared).

Modeled value ranks above 2% of those peers.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.